Lilly(Eli) & Company

NYSE: LLY
$796.28
+$28.52 (+3.7%)
Closing Price on December 23, 2024

LLY Articles

The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
24/7 Wall St. has reviewed Disney, General Motors, Twitter and some of the other key stocks reporting earnings this coming week.
The January 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly. The transaction is not subject to any financing condition and is expected to close by...
The December 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and other research calls from Thursday included Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael's and Target.
Eli Lilly shares were slightly lower after the company announced positive results from its late-stage active psoriatic arthritis study.
Eli Lilly shares rose slightly on Thursday after the company announced an FDA update on its treatment for systemic lupus erythematosus.
The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The top analyst upgrades, downgrades and initiations seen on Monday included American Eagle Outfitters, Eli Lilly, GameStop, Intuit, Novavax, Nvidia, Salesforce.com and Schlumberger.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.